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Background
Parkinson's disease (PD) comprises a range of motor and
cognitive disturbances, a portion of which respond little,
if at all, to levodopa treatment and are therefore consid-
ered to be due to nondopaminergic lesions [1,2]. More
severe cognitive impairments and higher risk for develop-
ing dementia have been associated with the clinical man-
ifestations of postural instability and gait disorder which
are characterized by refractoriness to levodopa [2,3].
Materials and methods
A consecutive series of non-demented PD patients
referred to our tertiary care centre received a comprehen-
sive neurological and neuropsychological evaluation in
their “on” state. Strict inclusion criteria were applied in
order to avoid the influence on cognitive outcomes of fac-
tors other than the clinical status of patients. The Unified
Parkinson's Disease Rating Scale (UPDRS) motor score
was divided into 2 subscores that represented predomi-
nantly dopaminergic (subscore A: tremor, rigidity, brady-
kinesia and facial expression) and nondopaminergic
(subscore B: speech and axial impairment) deficiency.
Overall cognitive status was rated with the Mini-Mental
State Examination (MMSE) and the presence of depressive
symptoms with the Beck Depression Inventory - Fast
screen. A neuropsychological test battery was further
administered to each patient to assess cognitive domains
known to be affected even in the early stages of PD, which
included the Rey Auditory Verbal Learning Test (RAVLT)
(verbal memory), the Trail Making Test (TMT) part B and
the Stroop Neuropsychological Screening Test (executive
functions), the Line Orientation Test (visuospatial percep-
tion), as well as the TMT part A and the Symbol Digit
Modalities Test (psychomotor speed and attention). In
addition, the intersecting pentagon copying item within
the MMSE was graded using a 0-2 rating scale (visuocon-
structional ability). Stepwise multiple regression analyses
were performed in order to model the effect of clinical
parameters on cognitive measures. The predictor variables
included age, age at onset of disease, years of education,
depression score, daily dose of levodopa, subscore A and
subscore B.
Results
A total of 42 patients (22 males, 20 females) with a mean
age of 64.9 ± 10.1 years, age at onset of PD of 58.2 ± 11.1
years, PD duration of 6.6 ± 5.3 years and education of 9.2
± 4.2 years were included. The best predictors of neu-
ropsychological performances were age, age at onset of
symptoms and years of education. Subscore A accounted
only for an additional 6.9% (p=0.038) of the variation of
the RAVLT trial 3 and subscore B for an additional 5.5%
(p=0.043) of the variation of the TMT part B, while both
subscores were excluded in models of all other measures.
Conclusions
Cognitive decline in PD patients might be owing to the
simultaneous effect of age-related and disease-associated
neuropathology. Development of impaired postural
reflexes and gait difficulties in patients does not appear to
be closely related to cognitive dysfunction, at least prior to
dementia.
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